IPCALAB — Ipca Laboratories Cashflow Statement
0.000.00%
- IN₹367.92bn
- IN₹384.90bn
- IN₹89.40bn
- 97
- 11
- 70
- 65
Annual cashflow statement for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 13,813 | 11,357 | 7,453 | 8,427 | 11,311 |
Depreciation | |||||
Non-Cash Items | -184 | -373 | -264 | 1,326 | 3,301 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4,819 | -4,707 | -1,747 | -3,114 | -5,377 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 10,901 | 8,602 | 8,058 | 10,212 | 13,213 |
Capital Expenditures | -3,616 | -4,790 | -4,945 | -4,113 | -7,756 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1,591 | -3,761 | -2,305 | -8,805 | -939 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5,207 | -8,551 | -7,250 | -12,918 | -8,695 |
Financing Cash Flow Items | -84.1 | -61.8 | -415 | -1,343 | -744 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,058 | 4,268 | 5,072 | -5,526 | -2,830 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,636 | 4,319 | 5,881 | -8,232 | 1,688 |